Seunghee Hong
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Notch2-expressing CD4+ T cells attain immunoregulatory functions during autoimmune inflammation.
Journal: Cellular & molecular immunology
Published: November 02, 2024
Gut microbiota promotes immune tolerance at the maternal-fetal interface.
Journal: Cell
Published: July 15, 2024
Microglial NLRP3-gasdermin D activation impairs blood-brain barrier integrity through interleukin-1β-independent neutrophil chemotaxis upon peripheral inflammation in mice.
Journal: Nature communications
Published: April 09, 2024
Mapping the immune cell landscape of severe atopic dermatitis by single-cell RNA-seq.
Journal: Allergy
Published: March 14, 2023
Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia.
Journal: Molecular cancer
Published: February 28, 2023
Corticosteroids reduce pathologic interferon responses by downregulating STAT1 in patients with high-risk COVID-19.
Journal: Experimental & molecular medicine
Published: June 03, 2022
Dual external field-responsive polyaniline-coated magnetite/silica nanoparticles for smart fluid applications.
Journal: Chemical communications (Cambridge, England)
Published: June 07, 2017
Discovery of new benzothiazole-based inhibitors of breakpoint cluster region-Abelson kinase including the T315I mutant.
Journal: Journal of medicinal chemistry
Published: April 23, 2013
Design, synthesis, and evaluation of 3,5-disubstituted 7-azaindoles as Trk inhibitors with anticancer and antiangiogenic activities.
Journal: Journal of medicinal chemistry
Published: May 12, 2012
Identification of common inhibitors of wild-type and T315I mutant of BCR-ABL through the parallel structure-based virtual screening.
Journal: Journal of computer-aided molecular design
Published: January 30, 2012
HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
Journal: Cancer letters
Published: October 04, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026